Cynthia Goldenberg Insider Profile
4 Followers
Cynthia Goldenberg, former President & CEO, Director at Immunomedics, holds 6.04M shares in Immunomedics (Ticker: IMMU). Most recently, Cynthia Goldenberg Sold 20,000 shares of Immunomedics on Sep 05, 2017 for an estimated value of $252.75K.
Cynthia Goldenberg's Trading History
You May Also Like
Cynthia Goldenberg insider profile FAQ
What is the percentage of profitable transactions made by Cynthia Goldenberg?
The percentage of profitable transactions made by Cynthia Goldenberg is 13%.
What is the average return per transaction made by Cynthia Goldenberg?
The average return per transaction made by Cynthia Goldenberg is -47.40%.
What stocks does Cynthia Goldenberg hold?
Cynthia Goldenberg holds: IMMU stocks.
What was Cynthia Goldenberg’s latest transaction?
Cynthia Goldenberg’s latest transaction was an Informative Sell of $252.75K.
What was Cynthia Goldenberg's most profitable transaction?
Cynthia Goldenberg’s most profitable transaction was an Informative Sell of IMMU stock on June 12, 2015. The return on the trade was 3.30%.
What is Cynthia Goldenberg's role in Immunomedics?
Cynthia Goldenberg's role in Immunomedics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
